Market Value347,863,000
Total Holdings70
File Date2021-11-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CCXI / ChemoCentryx Inc
NTRA / Natera, Inc.
ZYME / Zymeworks Inc.
ZY / Zymergen Inc
LHCG / LHC Group Inc
UHS / Universal Health Services, Inc.
ACHC / Acadia Healthcare Company, Inc.
DXCM / DexCom, Inc.
MRTX / Mirati Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
HZNP / Horizon Therapeutics Plc
AKRO / Akero Therapeutics, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
ARNA / Arena Pharmaceuticals Inc
KURA / Kura Oncology, Inc.
DNLI / Denali Therapeutics Inc.
CMRX / Chimerix, Inc.
ONEM / 1life Healthcare Inc
AVTX / Avalo Therapeutics, Inc.
AVIR / Atea Pharmaceuticals, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
PNTG / The Pennant Group, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
AGIO / Agios Pharmaceuticals, Inc.
AXGN / Axogen, Inc.
MCRB / Seres Therapeutics, Inc.
ATRA / Atara Biotherapeutics, Inc.
CVS / CVS Health Corporation
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
HMIN / Homeinns Hotel Group
KDMN / Kadmon Holdings Inc
MSON / Misonix Inc
ARDX / Ardelyx, Inc.
KPTI / Karyopharm Therapeutics Inc.
HRTX / Heron Therapeutics, Inc.
ALEC / Alector, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
AXNX / Axonics, Inc.
SGEN / Seagen Inc
IMGN / ImmunoGen, Inc.
ALT / Altimmune, Inc.
AERI / Aerie Pharmaceuticals Inc
LYEL / Lyell Immunopharma, Inc.
ZBH / Zimmer Biomet Holdings, Inc.
DTIL / Precision BioSciences, Inc.
TRIL / Trillium Therapeutics Inc
GMED / Globus Medical, Inc.
INSP / Inspire Medical Systems, Inc.
PTCT / PTC Therapeutics, Inc.
MGTA / Magenta Therapeutics Inc
MYOV / Myovant Sciences Ltd
RVNC / Revance Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
IRTC / iRhythm Technologies, Inc.
RVTY / Revvity, Inc.
UNH / UnitedHealth Group Incorporated
LFST / LifeStance Health Group, Inc.
MDT / Medtronic plc
SIBN / SI-BONE, Inc.
BIIB / Biogen Inc.
REPL / Replimune Group, Inc.
INSM / Insmed Incorporated
DHR / Danaher Corporation
CNC / Centene Corporation
MGNX / MacroGenics, Inc.
AGL / agilon health, inc.
ALKS / Alkermes plc
COR / Cencora, Inc.
RGNX / REGENXBIO Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
REGN / Regeneron Pharmaceuticals, Inc.
RLAY / Relay Therapeutics, Inc.
EW / Edwards Lifesciences Corporation
NVST / Envista Holdings Corporation
RETA / Reata Pharmaceuticals Inc - Class A
PTGX / Protagonist Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
FMTX / Forma Therapeutics Holdings Inc
BMRN / BioMarin Pharmaceutical Inc.
TFX / Teleflex Incorporated
NVRO / Nevro Corp.
FOLD / Amicus Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
PFE / Pfizer Inc.
ABBV / AbbVie Inc.
ELV / Elevance Health, Inc.
A / Agilent Technologies, Inc.
HOLX / Hologic, Inc.
BHVN / Biohaven Ltd.
CYTK / Cytokinetics, Incorporated
LBPH / Longboard Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
NTLA / Intellia Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.